160 HEALTH's stock plummeted 8.70% during intraday trading on Tuesday. The sharp decline follows a significant multi-session rally driven by positive company developments.

The recent surge was fueled by the company's announcement regarding its 160 AI Hospital partnership model, which had signed contracts with 102 public medical institutions as of March 31, including 54 top-tier Class 3A hospitals. The company also reported its first adjusted net profit, marking a financial turnaround.

Today's pullback appears consistent with previously flagged investment risks, including the company's persistently low gross margin in its pharmaceutical and health product segment and concerns over recent sharp price volatility, leading to profit-taking after the stock's elevated levels.